BMY or CIPLA.NS: which is the higher-quality business?
Same dated snapshot (2026-09-01): BMY scores 100/100 vs CIPLA.NS —/100 on the rule-based Berkshire checklist (very high vs unscored band). Quality grades the business only — the lower-quality name can still be the better deal at the right price.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| BMY (Bristol Myers) | CIPLA.NS (Cipla) | |
| Market / sector | us · Healthcare | in · Pharma |
| Price | $66.95 | ₹1,407 |
| Quality score | 100/100 | —/100 |
| Engine signal | LONG · 201 bars · uPnL +43.6% | LONG · 90 bars · uPnL +7.7% |
| Total return | +29.0% | +3.1% |
Cite this page
Balance Labs Research Desk (2026-09-01). "BMY or CIPLA.NS: which is the higher-quality business?." balancelabs.app · https://balancelabs.app/stocks/compare/bmy-vs-cipla.ns/q/bmy-or-cipla.ns-higher-quality · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← BMY vs CIPLA.NS · snapshot 2026-09-01 · not investment advice